SIGN INMYPAGE

The Liver Week 2025

  • INTRODUCTION
    • Highlights from
      TLW 2025
    • Welcome
    • Organization
    • Information
    • History
  • PROGRAM
    • Program at a Glance
    • Daily Program
    • Invited Faculty
    • Food & Beverage
    • Industry Symposia
  • ABSTRACT
    • Submission Guidelines
    • Presentation Guidelines
    • Award Program
  • REGISTRATION
    • Registration
    • 평점안내
  • VENUE
    • HICO
    • Accommodation
    • Transportation
    • Gyeongju
  • PARTNERSHIP
    • Partnership

PROGRAMThe Liver Week 2025A Big Welcome to the Liver Festival in Gyeongju, Korea!May 29-31, 2025IHICO, Gyeongju, Korea

PROGRAM AT A GLANCE DAILY PROGRAM INVITED FACULTY MEAL PLAN INDUSTRY SYMPOSIA
  • Thursday, May 29, 2025
  • Friday, May 30, 2025
  • Saturday, May 31, 2025
Time ROOM 1
(300B)
ROOM 2
(203+204)
ROOM 3
(205+206)
ROOM 4+5
(201+202)
Exhibition
Hall (300A+C)
Time
08:40-10:25 PG Course 1 (*K)Viral Hepatitis

08:40-10:25

Basic Research 1 (*K)

08:40-10:20

Booth
& Poster
Exhibition

08:40-17:20

08:40-10:25
10:25-10:40 Coffee Break

10:25-10:40

10:25-10:40
10:40-12:00 PG Course 2 (*K)Steatotic Liver Disease
and Liver Fibrosis

10:40-12:00

Basic Research 2 (*K)

10:40-12:00

10:40-12:00
12:00-12:50 Luncheon Symposium 1

12:00-12:50

Luncheon Symposium 2

12:00-12:50

12:00-12:50
12:50-13:40 Special Lecture (*K)

12:50-13:40

12:50-13:40
13:40-15:20 PG Course 3 (*K)Alcohol-Related Liver Disease
and Liver Cirrhosis

13:40-15:20

Young Investigator
Meeting


13:40-15:20

Ultrasound
Trainee Session (*K)


14:00-15:30

Ultrasound
Trainer Session 1 (*K)


14:00-15:30

13:40-15:30
15:20-15:40 Coffee Break

15:20-15:40

15:20-15:40
15:40-17:20 PG Course 4 (*K)Hepatic Tumor

15:40-17:20

Research Assistant
Program

15:40-17:10

Ultrasound
Hands-On Course (*K)

15:40-17:10

Ultrasound
Trainer Session 2 (*K)

15:40-17:10

15:40-17:20
18:00-20:00 Faculty Dinner

18:00-20:00

18:00-20:00

Please use the scroll bar underneath to view more program.

Time ROOM 1
(300B)
ROOM 2
(203+204)
ROOM 3
(205+206)
ROOM 4
(202)
ROOM 5
(201)
ROOM 6
(103+104)
ROOM 7
(105+106)
ROOM 8
(102)
ROOM 9
(101)
Exhibition
Hall (300A+C)
Time
07:30-08:50 KASL SIG 1The Korean Steatotic Liver Disease Study Group

07:30-08:50

KLCA
Symposium 1
Epidemiology & Surveillance of HCC

07:30-08:50

KAHBPS
Symposium 1
Considerations in Liver Surgery

07:30-08:50

KASL SIG 2The Korean Autoimmune and Rare Liver Disease Study Group

07:30-08:50

KASL SIG 3The Korean Abdominal Ultrasound Study Group

07:30-08:50

Translational Hepatology

07:30-08:50

Industry
Forum 1


08:00-08:50

Booth & Poster
Exhibition

08:00-16:30

07:30-08:50
08:50-09:10 Liver Biopsy
in HCC (*K)

08:50-09:10

08:50-09:10
09:10-10:30 KASL-AASLD
Joint Symposium 1
RCT in Hepatology

09:10-10:30

KLCA
Symposium 2
Biomarkers of Liver Cancer

09:10-10:30

KAHBPS
Symposium 2
Minimally Invasive Surgery

09:10-10:30

KASL
Symposium 1
LC and Portal HTN

09:10-10:30

Hepatology
Associates 1 (*K)
Clinical Hepatology

09:10-10:30

09:10-10:30
10:30-10:50 KASL Leading Research Achievement Award

10:30-10:50

Coffee Break

10:30-10:50

10:30-10:50
10:50-11:10 Opening Ceremony

10:50-11:10

10:50-11:10
11:10-11:40 State-of-the-Art Lecture

11:10-11:40

11:10-11:40
11:40-12:40 Plenary Presentation 1


11:40-12:40

KLTS Coordinator
Session (*K)
Liver Transplantation
for ALD

11:20-12:40

11:40-12:40
12:40-13:30 Luncheon
Symposium 3

12:40-13:30

KLCA
General Meeting

12:40-13:30

Luncheon
Symposium 4

12:40-13:30

Luncheon
Symposium 5

12:40-13:30

Luncheon
Symposium 6

12:40-13:30

12:40-13:30
13:30-14:50 KASL
Symposium 2
Chronic Viral Hepatitis

13:30-14:50

KLCA-JLCA
Joint Symposium
Pre- & Post-LT for HCC

13:30-14:50

KAHBPS
Symposium 3
Updates on Cholangiocarcinoma

13:30-14:50

TLW SIGPrecision Oncology


13:30-14:50

Data Science
Camp 1
Statistics in
Hepatology

13:30-14:50

Health Insurance/
Policy Forum (*K)

13:30-14:50

13:30-14:50
14:50-15:10 Coffee Break

14:50-15:10

14:50-15:10
15:10-16:30 KASL-KAHBPS-KLCA-KLTS
Joint Symposium
Multidisciplinary Practice

15:10-16:30

Free Paper 1

15:10-16:30

Free Paper 2

15:10-16:30

Free Paper 3

15:10-16:30

Free Paper 4

15:10-16:30

Free Paper 5

15:10-16:30

Hepatology
Associates 2 (*K)
Elements for
Clinical Trials

15:10-16:30

Free Paper 6

15:10-16:30

Free Paper 7

15:10-16:30

15:10-16:30
16:40-17:40 Poster Oral
Presentation

16:40-17:40

16:40-17:40
18:00- Welcome
Reception

18:00-

18:00-

Please use the scroll bar underneath to view more program.

Time ROOM 1
(300B)
ROOM 2
(203+204)
ROOM 3
(205+206)
ROOM 4
(202)
ROOM 5
(201)
ROOM 6
(103+104)
ROOM 7
(105+106)
ROOM 8
(102)
ROOM 9
(101)
Exhibition
Hall (300A+C)
Time
07:30-08:50 KASL SIG 4.The Korean Viral Hepatitis Study Group

07:30-08:50

KLCA
Symposium 3
New Paradigms of HCC Treatment

07:30-08:50

KLTS
Symposium 1
Pre-LDLT Approaches

07:30-08:50

KASL SIG 5. The Korean Study Group of Portal Hypertension

07:30-08:50

KASL SIG 6. The Korean Alcohol-Related Problem Study Group

07:30-08:50

Industry
Forum 2



08:00-08:50

07:30-08:50
09:10-10:30 KASL-AASLD
Joint Symposium 2
Future Hepatology

09:10-10:30

KLCA-TLCA
Joint Symposium
Strategies in the I-O Era

09:10-10:30

KLTS
Symposium 2
Techniques in LDLT

09:10-10:30

Data Science
Camp 2
AI in Hepatology

09:10-10:30

Poster Oral Presentation

09:30-10:30

09:10-10:30
10:30-10:50 Coffee Break

10:30-10:50

Booth &
Poster Exhibition

08:00-16:10

10:30-10:50
10:50-11:20 President's Choice Lecture

10:50-11:20

10:50-11:20
11:20-12:20 Plenary Session 2

11:20-12:20

11:20-12:20
12:20-13:10 Luncheon
Symposium 7

12:20-13:10

Luncheon
Symposium 8

12:20-13:10

Luncheon
Symposium 9

12:20-13:10

Luncheon
Symposium 10

12:20-13:10

Luncheon
Symposium 11

12:20-13:10

12:20-13:10
13:10-14:30 KASL Symposium 3MASLD


13:10-14:30

Free Paper 8

13:10-14:30

KLTS
Symposium 3
Pre-DDLT Approaches

13:10-14:30

Free Paper 9

13:10-14:30

Free Paper 10

13:10-14:30

KASL
Symposium 4
Alcohol-Associated
Liver Disease

13:10-14:30

Free Paper 11

13:10-14:30

Free Paper 12

13:10-14:30

Free Paper 13

13:10-14:30

13:10-14:30
14:30-14:50 Coffee Break

14:30-14:50

14:30-14:50
14:50-15:50 The Liver Week 2025
Debrief

14:50-15:50

14:50-15:50
15:50-16:10 Closing & Award

15:50-16:10

15:50-16:10

08:40-10:25

PG Course 1 (*K)
Viral Hepatitis

Chair: So Young Kwon (Konkuk Univ.). Sang Hoon Park (Hallym Univ.)

  • 08:40-09:05
  • Optimal Timing Antiviral Therapy for Hepatitis B Virus: When to Start and When to Stop?

    Jeong Eun Song (Daegu Catholic Univ.)

  • 09:05-09:30
  • Challenges and Future Directions for Hepatitis B Virus Cure

    Jung Hyun Kwon (The Catholic Univ. of Korea)

  • 09:30-09:55
  • Emerging Viral Hepatitis: New Insights into Hepatitis D and E Infections

    Seong Kyun Na (Inje Univ.)

  • 09:55-10:25
  • Updated KASL Guidelines on Chronic Hepatitis C

    Young Kul Jung (Korea Univ.)

10:40-12:00

PG Course 2 (*K)
Steatotic Liver Disease and Liver Fibrosis

Chair: Joo Hyun Sohn (Hanyang Univ.), Gab Jin Cheon (Univ. of Ulsan)

  • 10:40-11:05
  • From Chronic Inflammation to Fibrogenesis

    Won Sohn (Sungkyunkwan Univ.)

  • 11:05-11:30
  • Impact of Genetic and Environmental Risk Factors on Liver Fibrosis

    Ji-Won Park (Hallym Univ.)

  • 11:30-12:00
  • Updated KASL Guidelines on Metabolic Dysfunction-Associated Steatotic Liver Disease

    Byoung Kuk Jang (Keimyung Univ.)

12:50-13:40

Special Lecture (*K)

Chair: Han Chu Lee (Univ. of Ulsan)

  • 12:50-13:40
  • How Do Medical Policies and Media Work in an Aging Era?

    Dong-Chan Cho (Korea Science Journalists Association)

13:40-15:20

PG Course 3 (*K)
Alcohol-Associated Liver Disease and Cirrhosis

Chair: Hong Soo Kim (Soonchunhyang Univ.), Oh Sang Kwon (Gachon Univ.)

  • 13:40-14:05
  • Identification of High-Risk Groups in Alcohol-Associated Liver Disease

    Ha Il Kim (Hanyang Univ.)

  • 14:05-14:30
  • Therapeutic Strategies for Alcohol-Use Disorder and Alcoholic Hepatitis

    Jeong-Ju Yoo (Soonchunhyang Univ.)

  • 14:30-14:55
  • Medical and Interventional Treatments in Portal Hypertension

    Ki Tae Yoon (Pusan National Univ.)

  • 14:55-15:20
  • Recent Updates on Acute-on-Chronic-Liver-Failure Management

    Jong-In Chang (Chung-Ang Univ.)

15:40-17:20

PG Course 4 (*K)
Hepatic Tumor

Chair: Chang Hyeong Lee (Daegu Catholic Univ.), Byung Seok Lee (Chungnam National Univ.)

  • 15:40-16:05
  • Surveillance Programs for Hepatocellular Carcinoma According to Risk Factors

    Tae Hyung Kim (Korea Univ.)

  • 16:05-16:30
  • Neoadjuvant and Adjuvant Therapies for Hepatocellular Carcinoma

    Wonseok Kang (Sungkyunkwan Univ.)

  • 16:30-16:55
  • Rising Tide: Hepatocellular Adenomas in Korea

    So Yeon Kim (Univ. of Ulsan)

  • 16:55-17:20
  • Diagnosis and Treatment of Combined Hepatocellular Carcinoma-Cholangiocarcinoma

    Pil Soo Sung (The Catholic Univ. of Korea)

08:40-10:20

Basic Research 1 (*K)
Beginners' Guide for Basic Research

Chair: Jung-Hwan Yoon (Seoul National Univ.), Won-Il Jeong (KAIST)

  • 08:40-09:10
  • Why Hepatologists Should Engage in Basic and Translational Research

    Jeong Won Jang (The Catholic Univ. of Korea)

  • 09:10-09:40
  • Essential Steps to Setting Up a Hepatology Research Lab

    Young-Sun Lee (Korea Univ.)

  • 09:40-10:20
  • How to Interpret Basic Research Data in Hepatology

    Sejoon Lee (Seoul National Univ.)

10:40-12:00

Basic Research 2 (*K)
New Approaches in Translational Science

Chair: Neung Hwa Park (Univ. of Ulsan), Kyun-Hwan Kim (Sungkyunkwan Univ.)

  • 10:40-11:10
  • Advances in Spatial Omics and Data Analysis

    Jong-Eun Park (KAIST)

  • 11:10-11:35
  • Heterogeneity in Hepatocellular Carcinoma Diagnosis and Treatment via Spatial Gene Profiling

    Junil Kim (Soongsil Univ.)

  • 11:35-12:00
  • Digital Spatial Protein Profiling in Liver Diseases

    Ji Won Han (The Catholic Univ. of Korea)

13:40-15:20

Young Investigator Meeting

Chair: Joon Hyeok Lee (Sungkyunkwan Univ.), Won Young Tak (Kyungpook National Univ.)

  • 13:40-14:05
  • Distinguished Papers by Korean Hepatologists Aged 40 Years or Younger in 2024-2025

    Su Jong Yu (Seoul National Univ.)

    Introduction of Representative Studies

  • 14:05-14:20
  • Clinical Study 1

  • 14:20-14:35
  • Clinical Study 2

  • 14:35-14:50
  • Basic/Translational Study 1

  • 14:50-15:05
  • Basic/Translational Study 2

  • 15:05-15:20
  • Discussion

15:40-17:10

Research Assistant Program

Chair: Moon Seok Choi (Sungkyunkwan Univ.), Jong Eun Yeon (Korea Univ.)

  • 15:40-16:10
  • Artificial Intelligence Tools to Power Academic Research and Publication

    Joon Seo Lim (Scientific Publications Team, Asan Medical Center)

  • 16:10-16:40
  • Effective English Presentation and Communication in a Medical Conference

    Danielle Lee (Scientific Publications Team, Asan Medical Center)

  • 16:40-17:10
  • Management of Literature and References for Scientific Writing

    Sangzin Ahn (Inje Univ.)

14:00-15:30

Ultrasound Trainee Session (*K)

Chair: Moon Young Kim (Yonsei Univ. Wonju)

  • 14:00-14:20
  • What is an Abdominal Ultrasound?

    Seung Kak Shin (Gachon Univ.)

  • 14:20-14:40
  • Ultrasound Scanning Techniques: Liver

    Woo Sun Rou (Chungnam National Univ.)

  • 14:40-15:00
  • Ultrasound Scanning Techniques: Pancreato-Biliary

    Hae Lim Lee (The Catholic Univ. of Korea)

  • 15:00-15:20
  • Ultrasound Findings of Common Liver Diseases

    To Be Decided

  • 15:20-15:30
  • Q&A

15:40-17:10

Ultrasound Hands-On Course (*K)

  • 15:40-17:10
  • Group 1

    Jung Hee Kim (Hallym Univ.)

    Group 2

    Seul Ki Han (Yonsei Univ. Wonju)

    Group 3

    Hyun Yang (The Catholic Univ. of Korea)

    Group 4

    Tae Seop Lim (Yonsei Univ.)

14:00-15:30

Ultrasound Trainer Session 1 (*K)

Chair: Soon Koo Baik (Yonsei Univ. Wonju)

  • 14:00-14:20
  • Current Condition of Ultrasound Education in Training Hospitals

    Tae Suk Kim (Kangwon National Univ.)

  • 14:20-14:40
  • Point-of-Care Ultrasound (POCUS): An Invaluable Tool in the Field of Medical Procedure Services

    Nae-Yun Heo (Inje Univ.)

  • 14:40-15:00
  • Role of Ultrasound Methods for the Assessment of Metabolic Dysfunction-Associated Steatotic Liver Disease

    Se Young Jang (Kyungpook National Univ.)

  • 15:00-15:20
  • Liver Fibrosis Stages Using Ultrasound Technology

    Jung Gil Park (Yeungnam Univ.)

  • 15:20-15:30
  • Q&A

15:40-17:10

Ultrasound Trainer Session 2 (*K)

Chair: Jae Young Jang (Soonchunhyang Univ.)

  • 15:40-16:00
  • Follow-Up of Benign Neoplasm of Liver: Role of Abdominal Ultrasound

    Moon Hyung Lee (Kyung Hee Univ.)

  • 16:00-16:20
  • Fusion Imaging of Real-Time Ultrasonography with CT or MRI

    To Be Decided

  • 16:20-16:40
  • The Choice between Sonazoid and SonoVue

    Soo Young Park (Kyungpook National Univ.)

  • 16:40-17:00
  • Advanced Abdominal Ultrasound Considerations

    Sae Hwan Lee (Soonchunhyang Univ.)

  • 17:00-17:10
  • Q&A

07:30-08:50

KASL Special Interest Group 1. The Korean Steatotic Liver Disease Study Group

09:10-10:30

KASL-AASLD Joint Symposium 1
Randomized Controlled Trials in Hepatology

Chair: W. Ray Kim (Mayo Clinic, USA), Yoon Jun Kim (Seoul National Univ.)

  • 09:10-09:30
  • Practical Tips for Designing and Conducting Successful RCT

    Sumeet Asrani (Baylor Univ., USA)

  • 09:30-09:50
  • Biases, Challenges, and Innovations in RCT Statistics

    Inkyung Jung (Yonsei Univ.)

  • 09:50-10:10
  • Successes and Failures in RCT: Insights from AASLD Experiences

    Mazen Noureddin (Houston Methodist, USA)

  • 10:10-10:30
  • Successes and Failures in RCT: Insights from KASL Experiences

    Young-Suk Lim (Univ. of Ulsan)

11:10-11:40

State-of-the-Art Lecture

Chair: Masao Omata (The Univ. of Tokyo, Japan)

  • 11:10-11:40
  • HBV with Co-Existing Liver Diseases: The Interactions between Viral Hepatitis C, MAFLD, and HBV

    Chun-Jen Liu (National Taiwan Univ., Taiwan)

11:40-12:40

Plenary Presentation 1

Chair: Sung Su Yun (Yeungnam Univ.), Mi-Sook Kim (Korea Cancer Center Hospital), Yong-Han Paik (Sungkyunkwan Univ.)

13:30-14:50

KASL Symposium 2
The Immunological Horizon Towards Curing Viral Hepatitis and Beyond

Chair: Chun-Jen Liu (National Taiwan Univ., Taiwan), Sang Hoon Ahn (Yonsei Univ.)

  • 13:30-13:50
  • Pipelines for Curing Hepatitis B Using Immunological Targets: Successes and Failures

    Won-Mook Choi (Univ. of Ulsan)

  • 13:50-14:10
  • Targeting Innate Immunity as a Promising Approaches for Curing Hepatitis B

    Lung Yi Mak (The Univ. of Hong Kong, Hong Kong)

  • 14:10-14:30
  • Targeting Adaptive Immunity as a Promising Approaches for Curing Hepatitis B

    To Be Decided

  • 14:30-14:50
  • Development of a Novel Immune Modulator SA-5 as a Therapeutic Option for Chronic Hepatitis B

    Tatsuya Kanto (National Center for Global Health and Medicine, Japan)

15:10-16:30

KASL-KAHBPS-KLCA-KLTS Joint Symposium
Multidisciplinary Practices to Prevent Hepatocellular Carcinoma Occurrence and Recurrence

Chair: Tae Hun Kim (Ewha Womans Univ.), Dong-Hwan Jung (Univ. of Ulsan)

  • 15:10-15:30
  • Etiology-Based Primary Prevention Strategies for Hepatocellular Carcinoma

    Jeong Han Kim (Konkuk Univ.)

  • 15:30-15:50
  • Post-Resection Monitoring and Predictors for Hepatocellular Carcinoma Recurrence

    Min-Su Park (Kyung Hee Univ.)

  • 15:50-16:10
  • Diagnosis and Multidisciplinary Management of Recurrent Hepatocellular Carcinoma after Hepatectomy

    Hye Won Lee (Yonsei Univ.)

  • 16:10-16:30
  • Criteria and Workups for Liver Transplant Eligibility in Recipients

    Seok-Hwan Kim (Chungnam National Univ.)

07:30-08:50

KLCA Symposium 1
Evolving Epidemiology and Advancing Surveillance of Hepatocellular Carcinoma

Chair: Joong-Won Park (Myoungji Hospital, Hanyang Univ.), Jin Wook Chung (Seoul National Univ.)

  • 07:30-07:50
  • Trends from the Nationwide Cancer Registry

    Han Ah Lee (Chung-Ang Univ.)

  • 07:50-08:10
  • Future Trends in HCC Epidemiology in Korea

    Young Eun Chon (CHA Univ.)

  • 08:10-08:30
  • Imaging and Beyond: Expanding HCC Surveillance Modalities

    Hyuk Soo Eun (Chungnam National Univ.)

  • 08:30-08:50
  • The Future of Imaging-Based HCC Surveillance: Personalized Approaches and Artificial Intelligence

    Hyo Jung Park (Univ. of Ulsan)

08:50-09:10

Liver Biopsy in Hepatocellular Carcinoma (*K)

Chair: Kyung Sik Kim (Yonsei Univ.)

  • 08:50-09:10
  • Liver Biopsy in Hepatocellular Carcinoma

    Hae Lim Lee (The Catholic Univ. of Korea)

09:10-10:30

KLCA Symposium 2
Advancing Biomarker Discovery and Translational Insights in Liver Cancer

Chair: Seung Kew Yoon (The Catholic Univ. of Korea), Hee Chul Yu (Jeonbuk National Univ.)

  • 09:10-09:30
  • Liquid vs. Tissue Biopsy to Support Treatment Decisions in HCC

    Soung Won Jeong (Soonchunhyang Univ.)

  • 09:30-09:50
  • Artificial Intelligence-Based Pathology as a Biomarker of Sensitivity to Immunotherapy

    Sung Hak Lee (The Catholic Univ. of Korea)

  • 09:50-10:10
  • Targeting Tumor Microenvironment Biomarkers: Implications for Novel Therapies

    To Be Decided

  • 10:10-10:30
  • Application and Prospects of Single-Cell Sequencing in Liver Cancer

    Jungmin Choi (Korea Univ.)

13:30-14:50

KLCA-JLCA Joint Symposium
Optimizing Bridging Gaps in Pre- and Post-Liver Transplantation for Hepatocellular Carcinoma

Chair: June Sung Lee (Inje Univ.), Etsuro Hatano (Kyoto Univ., Japan)

  • 13:30-13:50
  • Pre-Transplant HCC Control: Surgical Resection and Bridging Strategies

    Jong Man Kim (Sungkyunkwan Univ.)

  • 13:50-14:10
  • Innovative Bridging Therapies for HCC: From Transarterial Chemoembolization to Immune Checkpoint Inhibitors

    Tomoharu Yamada (The Univ. of Tokyo, Japan)

  • 14:10-14:30
  • Post-Transplant HCC Recurrence: Predictors, Surveillance, and Novel Interventions

    Soon Sun Kim (Ajou Univ.)

  • 14:30-14:50
  • Immunosuppression and Immunotherapy in Post-Liver Transplant HCC: Striking the Right Balance

    Tomoharu Yoshizumi (Kyushu Univ., Japan)

07:30-08:50

KAHBPS Symposium 1
Assessment and Management of Uncommon Considerations in Liver Surgery

Chair: Chinburen Jigjidsuren (National Cancer Center, Mongolia), Young Chul Yoon (The Catholic Univ. of Korea)

  • 07:30-07:50
  • High-Grade Morbid Obesity

    Munkhbat Radnaabazar (National Cancer Center, Mongolia)

  • 07:50-08:10
  • Severe Cardiovascular Disease

    Haeil Jung (Soonchunhyang Univ.)

  • 08:10-08:30
  • Elderly Patients Over 75 Years

    Etsuro Hatano (Kyoto Univ., Japan)

  • 08:30-08:50
  • End-Stage Renal Disease

    Chan Woo Cho (Yeungnam Univ.)

09:10-10:30

KAHBPS Symposium 2
Laparoscopic Liver Resection vs. Robotic Liver Resection

Chair: Poowanai Sarkhampee (Chulalongkorn Univ., Thailand), Sang Jin Kim (Korea Univ.)

  • 09:10-09:30
  • Differences in Surgical Approaches

    Dai Hoon Han (Yonsei Univ.)

  • 09:30-09:50
  • Challenges and Learning Curve for Beginners

    Su Young Hong (National Cancer Center)

  • 09:50-10:10
  • Complications and Outcomes

    Kwan Woo Kim (Dong-A Univ.)

  • 10:10-10:30
  • Open Liver Resection as a Good Surgical Approach: Indications and Outcomes

    Kwangho Yang (Pusan National Univ.)

11:20-12:40

KLTS Coordinator Session (*K)
Multidisciplinary Approach to Liver Transplantation for Alcohol-Associated Liver Disease

Chair: Seung Heui Hong (Samsung Medical Center), Hae Won Lee (Seoul National Univ.)

  • 11:20-11:40
  • Alcohol Dependence and Liver Transplantation: The Importance of Mental Health Care

    Kye-Seong Lee (Incheon Chamsarang Hospital)

  • 11:40-12:00
  • Liver Transplantation for Alcohol-Associated Liver Disease: Surgical Perspective and Prognosis

    Hae Won Lee (Seoul National Univ.)

  • 12:00-12:20
  • Coordination of the Liver Transplant Process and Managing Patients with Alcohol-Associated Liver Disease

    Sunyoung Son (Gangnam Severance Hospital)

  • 12:20-12:40
  • Social Support and Rehabilitation for Liver Transplant Patients with Alcohol-Associated Liver Disease

    Eunseon Suh (Hwaseong Community Addiction Management Center)

13:30-14:50

KAHBPS Symposium 3
Recent Updates in Cholangiocarcinoma

Chair: Jin-Young Jang (Seoul National Univ.), Jaehong Jeong (Soonchunhyang Univ.)

  • 13:30-13:50
  • Minimal Invasive Surgery for Intrahepatic Cholangiocarcinoma

    Kyeong Deok Kim (Inha Univ.)

  • 13:50-14:10
  • Extent of Lymph Node Dissection in Intrahepatic Cholangiocarcinoma

    Poowanai Sarkhampee (Sunpasitthiprasong Hospital, Thailand)

  • 14:10-14:30
  • Surgical Approaches for Hilar Cholangiocarcinoma

    Sang Hwa Song (Chonnam National Univ.)

  • 14:30-14:50
  • Neoadjuvant and Adjuvant Therapy

    To Be Decided

07:30-08:50

KASL Special Interest Group 2. The Korean Autoimmune and Rare Liver Disease Study Group

09:10-10:30

KASL Symposium 1
Innovative Strategies in Cirrhosis Care

Chair: Barjesh Chander Sharma (Govind Ballabh Pant Hospital, India), Jae Young Jang (Soonchunhyang Univ.)

  • 09:10-09:30
  • Primary Hemostasis in Cirrhosis: A Modern Perspective on Coagulopathy

    Manoj Kumar Sharma (Institute of Liver and Biliary Sciences, India)

  • 09:30-09:50
  • Metabolomic Biomarkers for Risk Stratification and Prognosis Prediction in Cirrhotic Patients

    Eun Ju Cho (Seoul National Univ.)

  • 09:50-10:10
  • Recompensation in Cirrhosis: Mechanisms, Predictors, and Therapeutic Strategies

    Byeong Geun Song (Sungkyunkwan Univ.)

  • 10:10-10:30
  • Treatment of Portal Hypertension in Patients with Hepatocellular Carcinoma in the Era of Baveno VII

    Dominique Thabut (Sorbonne Univ., France)

13:30-14:50

TLW Special Interest Group
Integrating Multi-Omics for Precision Oncology

Chair: Chien-Hung Chen (National Taiwan Univ., Taiwan), Jaeyoun Cheong (Ajou Univ.)

  • 13:30-13:50
  • Integration of Clinical, Computational, and Genomic Resources for Early HCC Detection

    Augusto Villanueva (Icahn School of Medicine at Mount Sinai, USA)

  • 13:50-14:10
  • Molecular Insights into HCC Recurrence from Minimal Residual Disease after Therapy

    Renumathy Dhanasekaran (Stanford Univ., USA)

  • 14:10-14:30
  • Immune Microenvironment and Therapeutic Discovery in HCC Using Single-Cell Omics Analysis

    Valerie Chew (Duke-NUS Medical School, Singapore)

  • 14:30-14:50
  • Genomic Characteristics of RB1-Deficient HCC and Its Therapeutic Candidates

    Ju Hyun Shim (Univ. of Ulsan)

07:30-08:50

KASL Special Interest Group 3. The Korean Abdominal Ultrasound Study Group

09:10-10:30

Hepatology Associates 1 (*K)
Updates in Clinical Hepatology

Chair: Jaeseok Hwang (Keimyung Univ.), Hee Bok Chae (Chungbuk National Univ.)

  • 09:10-09:30
  • Percutaneous Liver Biopsy: When to Decide to Perform and How to Minimize Risk

    Hyeon Ji Jang (Univ. of Ulsan)

  • 09:30-09:50
  • Management of Hospitalized Patients with Alcohol Withdrawal Syndrome

    Jae Hyun Yoon (Chonnam National Univ.)

  • 09:50-10:10
  • Inpatient Care for Gastrointestinal Bleeding in Patients with Liver Cirrhosis

    Heechul Nam (The Catholic Univ. of Korea)

  • 10:10-10:30
  • Precipitating Factors and Management of Hepatic Encephalopathy

    Jae Seung Lee (Yonsei Univ.)

13:30-14:50

Data Science Camp 1
Statistics in Hepatology

Chair: Jin-Wook Kim (Seoul National Univ.), Chang Wook Kim (The Catholic Univ. of Korea)

  • 13:30-14:10
  • Advanced Survival Analysis

    Woojoo Lee (Seoul National Univ.)

  • 14:10-14:50
  • Development and Evaluation of Clinical Prediction Models

    Se Hee Kim (Univ. of Ulsan)

15:10-16:30

Hepatology Associates 2 (*K)
Essential Elements for a Successful Clinical Trial

Chair: Young Seok Kim (Soonchunhyang Univ.), Byung-Cheol Song (Jeju National Univ.)

  • 15:10-15:30
  • Differences between Sponsor-Initiated Trials and Investigator-Initiated Trials

    Minjong Lee (Ewha Womans Univ.)

  • 15:30-15:50
  • Human Subjects Protection and Data Review Board

    Seung Won Jeung (Korea Health Information Service)

  • 15:50-16:10
  • Collection and Management of Patient-Derived Samples in Clinical Trials

    Dae Won Jun (Hanyang Univ.)

  • 16:10-16:30
  • Keywords for Investigator-Initiated Trials

    Elisabet Kim (Asan Medical Center)

07:30-08:50

Translational Hepatology
Promising Cutting-Edge Translational Liver Study

Chair: Youngmi Jung (Pusan National Univ.), Ja Hyun Koo (Seoul National Univ.)

  • 07:30-07:50
  • Tracing Cellular Dynamics during Intestinal Tumorigenesis and Metastasis

    Min Kyu Yum (KAIST)

  • 07:50-08:10
  • Histone Lactylation: A Novel Epigenetic Mark in Liver Fibrosis

    Hyun Soo Rho (Ewha Womans Univ.)

  • 08:10-08:30
  • Casp2: The New Hepatic Lipid Regulator

    Ju Youn Kim (Hanyang Univ.)

  • 08:30-08:50
  • Identification of Novel Targets for the Treatment of MASLD

    Keon Wook Kang (Seoul National Univ.)

07:30-08:50

KASL Special Interest Group 4. The Korean Viral Hepatitis Study Group

09:10-10:30

KASL-AASLD Joint Symposium 2
Looking into the Future of Hepatology

Chair: Silvia C. Sookoian (Maimonides Univ., Argentina), Sook-Hyang Jeong (Seoul National Univ.)

  • 09:10-09:30
  • Anti-Fibrotic and Anti-Cirrhotic Approaches in Chronic Liver Disease

    Seung Up Kim (Yonsei Univ.)

  • 09:30-09:50
  • Future Directions in Liver Transplant Allocation Policies: Beyond MELD

    W. Ray Kim (Mayo Clinic, USA)

  • 09:50-10:10
  • Gut Microbiome-Targeted Therapies to Enhance Treatment Outcomes of Liver Diseases

    Ki Tae Suk (Hallym Univ.)

  • 10:10-10:30
  • Molecular and Immunological Biomarkers for Hepatocellular Carcinoma to Guide Personalized Treatment Decisions

    Renumathy Dhanasekaran (Stanford Univ., USA)

10:50-11:20

President's Choice Lecture

Chair: Yoon Jun Kim (Seoul National Univ.)

  • 10:50-11:20
  • Management of Portal Hypertension in Advanced Cirrhosis

    Shiv Kumar Sarin (Institute of Liver and Biliary Sciences, India)

11:20-12:20

Plenary Presentation 2

Chair: June Sung Lee (Inje Univ.), Si Hyun Bae (The Catholic Univ. of Korea), Kwang-Woong Lee (Seoul National Univ.)

13:10-14:30

KASL Symposium 3
Emerging Concepts, Challenges, and Therapeutic Frontiers of MASLD

Chair: Tatsuya Kanto (National Center for Global Health and Medicine, Japan), Won Kim (Seoul National Univ.)

  • 13:10-13:30
  • Identification of Genes Conferring Individual-Level Variation Responsible for MASLD Using Single-Cell eQTL Analysis

    Murim Choi (Seoul National Univ.)

  • 13:30-13:50
  • GLP-1 Receptor Agonists in MASLD: Current Clinical Status and Future Directions

    Sang Bong Ahn (Eulji Univ.)

  • 13:50-14:10
  • Resmetirom's Promise and the Challenges Ahead

    Mazen Noureddin (Houston Methodist, USA)

  • 14:10-14:30
  • New Drug Discovery Based on Multi-Omics

    Silvia C. Sookoian (Maimonides Univ., Argentina)

14:50-15:50

The Liver Week 2025 Debrief

Chair: Ju Hyun Shim (KASL), Su Jong Yu (KLCA), Hae Won Lee (KLTS)

  • 14:50-15:05
  • KASL

    Eun Sun Jang (Seoul National Univ.)

  • 15:05-15:20
  • KLCA

    Yuri Cho (National Cancer Center)

  • 15:20-15:35
  • KAHBPS

    Min-Su Park (Kyung Hee Univ.)

  • 15:35-15:50
  • KLTS

    Suk Kyun Hong (Seoul National Univ.)

07:30-08:50

KLCA Symposium 3
Revisiting and Expanding Hepatocellular Carcinoma Treatment Paradigms: From Standard to Innovative Therapies

Chair: Jong Young Choi (Chung-Ang Univ.), Augusto Villanueva (Icahn School of Medicine at Mount Sinai, USA)

  • 07:30-07:50
  • Systemic Therapy and Transarterial Chemoembolization in BCLC Intermediate Stage: A Survival Boost?

    Yi-Hsiang Huang (National Yang Ming Chiao Tung Univ., Taiwan)

  • 07:50-08:10
  • TACE/TARE in Advanced HCC: Can They Coexist with Systemic Therapy?

    Hyo-Cheol Kim (Seoul National Univ.)

  • 08:10-08:30
  • The Emerging Role of Immuno-Oncology Therapy in Neo- and Adjuvant Treatment for HCC

    To Be Decided

  • 08:30-08:50
  • Cancer Vaccines in HCC: Current Status and Future Directions

    Jeong Heo (Pusan National Univ.)

09:10-10:30

KLCA-TLCA Joint Symposium
Innovating and Expanding Surgical Horizons for Hepatocellular Carcinoma in the Immunotherapy Era

Chair: Kyung Sik Kim (Yonsei Univ.), Yi-Hsiang Huang (National Yang Ming Chiao Tung Univ., Taiwan)

  • 09:10-09:30
  • Surgical Innovations for Advanced HCC in the Immunotherapy Era: Korean Expertise

    Gi Hong Choi (Yonsei Univ.)

  • 09:30-09:50
  • Advancing Liver Surgery in the Immunotherapy Era: The Taiwanese Experience

    Ming-Chin Yu (Chang Gung Univ., Taiwan)

  • 09:50-10:10
  • Combining Immunotherapy with Local Treatments: New Directions for HCC Management in Kore

    Yun Bin Lee (Seoul National Univ.)

  • 10:10-10:30
  • Immune Checkpoint Inhibitors and Biomarker Discovery: Tailoring Treatment for HCC

    Chien-Hung Chen (National Taiwan Univ., Taiwan)

07:30-08:50

KLTS Symposium 1
Living Donor Liver Transplantation-Based Protocol for Hepatocellular Carcinoma: Intention-to-Treat Approach with Pre-Transplant Therapy

Chair: Myoung Soo Kim (Yonsei Univ.), Il Han Song (Dankook Univ.)

  • 07:30-07:50
  • Definition and Current Status of Bridging, Neoadjuvant, Downstaging, and Conversion Therapies

    Moon Haeng Hur (Seoul National Univ.)

  • 07:50-08:10
  • Pros and Cons of Repetitive Transarterial Chemoembolization or Other Locoregional Therapies Prior to Liver Transplantation 

    Dong Ho Hyun (Sungkyunkwan Univ.)

  • 08:10-08:30
  • Practical Factors Considered in Immunotherapy Prior to Liver Transplantation

    Dong Hyun Sinn (Sungkyunkwan Univ.)

  • 08:30-08:50
  • Lessons for Developing Protocols Based on Real-World Data

    Dong-Hwan Jung (Univ. of Ulsan)

09:10-10:30

KLTS Symposium 2
Technical Hurdles in Living Donor Liver Transplantation

Chair: Dong-Sik Kim (Korea Univ.), Munkhbat Radnaabazar (National Cancer Center, Mongolia)

  • 09:10-09:30
  • Outflow Reconstruction Tips in Liver Transplant for Budd-Chiari Syndrome

    Gyu-seong Choi (Sungkyunkwan Univ.)

  • 09:30-09:50
  • Portal Vein Reconstruction in a Recipient with Atretic Portal Vein

    Kwang-Woong Lee (Seoul National Univ.)

  • 09:50-10:10
  • Difficult Arterial Reconstruction: Multiple Arteries or Size-Mismatched Situations

    Chul Soo Ahn (Univ. of Ulsan)

  • 10:10-10:30
  • Various Bile Duct Anastomosis Methods for Multiple Duct Situations

    Tae-Seok Kim (Keimyung Univ.)

13:10-14:30

KLTS Symposium 3
Frontline Approaches in Deceased Donor Liver Transplantation: Optimizing Outcomes with Limited Liver Grafts

Chair: Yang Won Nah (Univ. of Ulsan), Young Kyoung You (The Catholic Univ. of Korea)

  • 13:10-13:30
  • Beyond the Present Korean Allocation System: Optimal Evaluation and Management of Patients on the Liver Transplant Waitlist

    Gi-Won Song (Univ. of Ulsan)

  • 13:30-13:50
  • Patient Selection and Timing of Referral for Liver Transplantation in Acute Alcoholic Hepatitis

    Do Seon Song (The Catholic Univ. of Korea)

  • 13:50-14:10
  • Perioperative Challenges and Solutions for Patients with Chronic Liver Disease Undergoing Deceased Donor Liver Transplantation

    Young Chul Yoon (The Catholic Univ. of Korea)

  • 14:10-14:30
  • Predicting Futile Outcomes in Deceased Donor Liver Transplantation: Focus on Acute-on-Chronic Liver Failure

    YoungRok Choi (Seoul National Univ.)

07:30-08:50

KASL Special Interest Group 5. The Korean Study Group of Portal Hypertension

09:10-10:30

Data Science Camp 2
Artificial Intelligence in Hepatology

Chair: Jin-Woo Lee (Inha Univ.), Kang Mo Kim (Univ. of Ulsan)

  • 09:10-09:35
  • Hepatic Applications of Artificial Intelligence

    Seung Soo Lee (Univ. of Ulsan)

  • 09:35-10:00
  • Artificial Intelligence for Clinical Prediction

    Beom Kyung Kim (Yonsei Univ.)

  • 10:00-10:30
  • Imaging Reconstruction for AI Models

    Jong Chul Ye (KAIST)

13:10-14:30

KASL Symposium 4
Integrative Approaches to Alcohol-Related Hepatic Disorders

Chair: Dominique Thabut (Sorbonne Univ., France), Sang Gyune Kim (Soonchunhyang Univ.)

  • 13:10-13:30
  • Sex and Gender Differences in Alcohol-Associated Liver Disease

    Young Chang (Soonchunhyang Univ.)

  • 13:30-13:50
  • Differentiating Neurological Manifestations in Alcohol-Associated Liver Disease

    Barjesh Chander Sharma (Govind Ballabh Pant Hospital, India)

  • 13:50-14:10
  • Emerging Regimens Competing with Glucocorticoids for Severe Alcoholic Hepatitis

    Sumeet Asrani (Baylor Univ., USA)

  • 14:10-14:30
  • Multidisciplinary Approaches to Treat Alcohol-Associated Liver Disease

    Seong Hee Kang (Korea Univ.)

07:30-08:50

KASL Special Interest Group 6. The Korean Alcohol-Related Problem Study Group
KASL-BATL Joint Session: Alcohol and Environmental Cues in Liver Disease

Chair: Wonhyo Seo (Ewha Womans Univ.), Yoon Mee Yang (Kangwon National Univ.)

  • 07:30-07:50
  • Hepatic Glutamate Signaling Pathway in Alcohol-Associated Liver Disease

    Won-Il Jeong (KAIST)

  • 07:50-08:10
  • IRONing Out MASLD: Hepatocyte Messages to Adipose Tissue

    Chang Yeob Han (Jeonbuk National Univ.)

  • 08:10-08:30
  • Calibration of Gut-Liver Axis via Bile Acid and Neutrophils

    Yong-Hyun Han (Kangwon National Univ.)

  • 08:30-08:50
  • Diagnosis and Treatment of Liver Disease Using Extracellular Vesicles

    Shuji Terai (Niigata Univ., Japan)

The Liver Week 2025

SECRETARIAT OF THE LIVER WEEK 2025

HB&I, #1711, Hanshin Building, Mapo-daero, Mapo-gu, Seoul, Korea, 04175

Tel: +82-2-373-1005    I    Fax: +82-2-373-1106
E-mail: theliverweek@hbni.co.kr

The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero (MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, Korea, 04185

TEL: +82-2-703-0051    I    Fax: +82-2-703-0071
E-mail: kasl@kams.or.kr